UPDATE 3-Eylea powers Regeneron's third-quarter profit beat; shares rise
November 05, 2019 at 10:38 AM EST
Nov 5 - Drugmaker Regeneron Pharmaceuticals Inc beat analysts' estimates for third-quarter profit on Tuesday, boosted by higher demand for its blockbuster eye drug, Eylea, and eczema therapy Dupixent.
